Clik here to view.
Hatchtech Announces Successful Phase 3 Study Results for Xeglyze™ Lotion
MELBOURNE, Australia Specialty pharmaceutical company Hatchtech Pty Ltd today announced positive results from its two pivotal Phase 3 clinical studies evaluating Xeglyze™ Lotion (formerly DeOvo...
View ArticleClik here to view.
Teleflex to Present for the First Time at the 32nd Annual World Congress of...
WAYNE, Pa. Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present for the first time at the 32nd Annual World Congress...
View ArticleClik here to view.
Clik here to view.
CartiHeal Granted Four Patents Covering Agili-C™ Cartilage Regeneration...
KFAR SABA, Israel CartiHeal (2009) Ltd., a privately held medical device company headquartered in Kfar Saba, Israel, announces the issuance of four patents — three in the U.S. and one in Japan — for...
View ArticleClik here to view.
China’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase Skin...
EMERYVILLE, Calif. & SHANGHAI NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective...
View ArticleClik here to view.
BSD Medical Completes Sale of Fourth BSD-2000 Hyperthermia System to Taiwan...
SALT LAKE CITY BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced...
View ArticleClik here to view.
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) has entered an exclusive agreement with a wholly-owned subsidiary of Hainan Sinotau Pharmaceutical Co., Ltd., a pharmaceutical...
View ArticleClik here to view.
Discover the Latest in Forensics at the 25th Annual International Symposium...
MADISON, Wis. When the International Symposium on Human Identification (ISHI) began in 1989, forensics was an emerging science, rife with possibilities. Few could have predicted that 25 short years...
View ArticleClik here to view.
Shionogi Inc. Enlists BuzzeoPDMA, a Cegedim Company to Support their Sample...
BEDMINSTER, N.J. BuzzeoPDMA, A Cegedim Company, today announced that Shionogi Inc. has selected BuzzeoPDMA’s sample management services to help the company maintain compliance with the FDA’s PDMA...
View ArticleClik here to view.
Rheonix Lectures in China on Its Innovative Molecular Platform
ITHACA, N.Y. Rheonix, Inc., a developer of fully automated molecular testing solutions, recently spoke at Beijing University of Chemical Technology, School of Information and Technology. Dr....
View ArticleClik here to view.
TEAC Introduces UR-4MD: It’s Never Been So Easy to Capture & Reliably Store...
TOKYO TEAC Corporation (hereinafter TEAC) (TOKYO:6803), the world leader in medical imaging, recording and filing solutions, today announced a new high-definition medical imaging recorder to be...
View ArticleClik here to view.
KCI、LifeCell和Systagenix合并为一家公司，品牌重塑为Acelity
圣安东尼奥 (美国商业资讯) — Centaur Guernsey L.P. Inc. (Centaur)今天宣布成立Acelity，对自身及其子公司Kinetic Concepts, Inc. (KCI)、LifeCell Corporation (LifeCell)和Systagenix Wound Management, Limited (Systagenix)成功进行了品牌重塑。...
View ArticleClik here to view.
KCI、ライフセル、シスタジェニックスが統合し、新ブランドAcelityとして一社に
サンアントニオ （ビジネスワイヤ） — セントーア・ガーンジー（セントーア）は本日、Acelityの始動を発表しました。Acelityは、当社および当社子会社のキネティック・コンセプツ（KCI)、ライフセル・コーポレーション(ライフセル)、シスタジェニックス・ウンド・マネジメント(シスタジェニックス)を効果的にリブランディングするものです。 Acelity...
View ArticleClik here to view.
米国ボストン・ストラテジクス社: 次世代型医薬品R&Dプラットフォーム（“True” Open Innovation™）を駆使してグローバル医薬品開発
ボストン （ビジネスワイヤ） — Boston Strategics Corporation（BSC）は、米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発（R&D）会社です。既成インフラに依らず、独自のグローバル・ネットワークを駆使する“True” Open Innovation™...
View ArticleClik here to view.
Toshiba Collaborates with Johns Hopkins University on Big Data Healthcare...
TOKYO To further the potential of Big Data to predict and prevent illness, Toshiba Group has established the Toshiba Center for Big Data in Healthcare at the Science + Technology Park at Johns...
View ArticleClik here to view.
Sosei Group Announces Positive Results for Ultibro® and Seebri® Presented at...
TOKYO Sosei Group Corporation (“Sosei”)(TOKYO:4565) confirms the new data from three clinical trials presented by Novartis at the European Respiratory Society (ERS) International Congress, September...
View ArticleClik here to view.
東芝：業界最小パッケージのフォトリレーのラインアップ拡充について
東京 （ビジネスワイヤ） — 東芝は、業界最小［注１］となるVSON4［注２］パッケージのフォトリレー製品として半導体テスタ用途の4製品「TLP3417」、「TLP3420」、「TLP3440」、「TLP3475」を追加し、本日から量産出荷を開始します。本製品は、半導体テスタ、計測器、プローブカード、医療機器などの応用機器に適した製品です。 東芝：業界最小VSON4パッケージのフォトリレー...
View ArticleClik here to view.
Toshiba Expands Lineup of Photorelays in Industry’s Smallest Package
TOKYO Toshiba Corporation (TOKYO:6502) today announced that it will expand its lineup of photorelays in the industry’s smallest[1] package with the addition of four products: “TLP3417”, “TLP3420”,...
View ArticleClik here to view.
Asfotase Alfa Granted Orphan Drug Designation in Japan
CHESHIRE, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to asfotase alfa for...
View ArticleClik here to view.
Mazor Robotics Receives China Cfda Approval for Its Renaissance Systems
CAESAREA, Israel Mazor Robotics Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that the China Food and Drug Administration...
View Article